Track topics on Twitter Track topics that are important to you
CUH2A is a recognized leader in the planning and design of technologically complex facilities for science and technology organizations. We have dedicated our practice to serving pharmaceutical, government, institutional research, academic, corporate and emerging technology clients with their research facility requirements for 40 years.The name “CUH2A” is an acronym derived from the first initials of the last name of the original five partners: Philip S. Collins, Harrison J. Uhl, Jr., Richard W. Hoisington, Kurt M. Anderson, and Ahmed A. Azmy. Collins founded the firm in 1962 when he won the design competition for the 1964 New York World’s Fair New Jersey Pavilion. Uhl and Hoisington joined him to assist with the pavilion’s contract documents and field inspection. Anderson joined the firm in 1965. The firm adopted its present name in 1976 when Azmy joined, completing the “2A”.
Since 1962, CUH2A has grown in size from three founding partners to several hundred design professionals; our guiding principles have remained the same.
21 Wootton Street
From BIO-Europe, the biggest pharma and biotech partnering meeting in Europe, Scrip lists the five hottest topics of discussion and...
(Potsdam Institute for Climate Impact Research (PIK)) Rising temperatures due to greenhouse gas emissions will fundamentally change electricity consumption patterns in Europe. A team of scientists fro...
I interviewed Kate Bingham of SV Health Investors about Alzheimer’s, checkpoint inhibitors, gender diversity and more at BIO Europe. BIO Europe 2017 was off to a racing start on Monday morning w...
By Antonio Parrinello and Steve Scherer CATANIA, Italy (Reuters) - A dozen far-right millennials from Europe and North America plan to set sail next week to "defend Europe" from what they call a migr...
Analysts predict Kymriah could become a $1bn-plus product in Europe
Hackers have caused widespread disruption across Europe, hitting Ukraine especially hard.
Families from across Europe are on Tuesday having their say on an epilepsy drug that raises the risk…
Drug becomes first targeted biologic in Europe to treat moderate-to-severe atopic dermatitis (AP)
Nizatidine Capsules USP Rx only
MANICURE by OPI FINISHING BUTTER
Retavase Reteplase, recombinant
Airway stenting (AS) commenced in Europe circa 1987 with the first placement of a dedicated silicone airway stent. Subsequently, over the last 3 decades, AS was spread throughout Europe, using differe...
The proportion of females among neurosurgeons appears to be growing worldwide with time. Official data concerning the current situation across Europe have not yet been published. Thus, there are still...
Are there any changes in the treatments involving ART and IUI initiated in Europe during 2013 compared with previous years?
The burden of cardiovascular disease is increasing worldwide, which has to be reflected by cardiovascular (CV) research in Europe. CardioScape, a FP7 funded project initiated by the European Society o...
To describe the infrastructural differences in training in Obstetrics and Gynaecology (ObGyn) across Europe.
This study is conducted in Europe. The aim of this study is to investigate usage of liraglutide for weight management in clinical practice.
This multicenter, prospective, single-arm, phase 3 study will assess the proportion of disease-free patients, starting from administration of the first study treatment to at least 12-month...
The investigators want to identify and show differences in standards and procedures of in-hospital rapid sequence induction by collecting data with an online survey for anaesthetist in Eur...
This is a prospective, non-interventional study (NIS) measuring health-related quality of life (HRQoL), treatment satisfaction, and other patient-reported outcomes (PROs) of ADPKD patients...
The main objective is to replicate the validation of omics biomarkers of left ventricular diastolic dysfunction in patients with metabolic syndrome. The aim was to recruit overall 750 pa...
CUH2A is a recognized leader in the planning and design of technologically complex facilities for science and technology organizations. We have dedicated our practice to serving the needs of instituti...
CUH2A is a recognized leader in the planning and design of technologically complex facilities for science and technology organizations. We have dedicated our practice to serving pharmaceutical, govern...
Europe Unlimited profiles and connects the community of Europe’s best tech entrepreneurs and international capital through research, networking events and consulting. As such, we are in a position t...
âWe are the gateway to Europe for U.S.-based medical technology companies.â Rick Hughes, President, HealthLink Europe
TESCOM EUROPE offers customized solutions and services for all pressure and flow control applications. We design, engineer, manufacture and install components and automated systems for pressure and fl...
We have published hundreds of CUH2A Europe, Inc. news stories on BioPortfolio along with dozens of CUH2A Europe, Inc. Clinical Trials and PubMed Articles about CUH2A Europe, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of CUH2A Europe, Inc. Companies in our database. You can also find out about relevant CUH2A Europe, Inc. Drugs and Medications on this site too.